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1. Introduction 
The molecular mechanisms forming the basis of the 
functional properties of hemoglobin are currently a 
subject of active investigation 
occurring on 
binding of ligands is the careful of the func- 
tional behaviour abnormal 
primary structure. This is particularly fruitful 
possible to correlate findings on the 
functional molecule with the struc- 
tural information analysis of the 
tridimensional structure [2] . 
Hemoglobin Rainier is a variant whose abnormality 
has been recently identified as the replacement of 
tyrosine HC2(145)0 by cysteine [3] . Crystallographic 
studies have also shown that the new residue (cysteine) 
introduced as a result of the mutation forms a disul- 
phide bridge with cysteine F9(93)P of the same 0 
chain, and it has been suggested that the formation of 
this disulphide bridge interferes with the structural 
mechanism invoked for hemoglobin function [4]. 
In view of the large body of knowledge now avail- 
able on hemoglobin Rainier it seemed important to 
reinvestigate in detail the equilibrium and kinetics of 
ligand binding by this abnormal protein. Previous 
* A preliminary account of the results reported here has 
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273. 
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studies [5] have been performed with whole blood; 
the few data on purified hemoglobin Rainier, quoted 
in reference [4] , have not been described in extenso. 
Particularly, for an unequivocal interpretation of 
the effects of the structural abnormality in hemo- 
globin Rainier, it would appear critical to know i) the 
exact magnitude of the Bohr effect, ii) the existence 
(if any) of heme-heme interaction, iii) the possible 
interference of intramolecular heterogeneity in deter- 
mining the functional properties. This forms the 
object of the present paper. 
2. Experimental 
The hemolysate containing the abnormal protein 
was adsorbed onto a CM-Sephadex column (20 X 200 
mm) equilibrated with a 0.01 M phosphate buffer pH 
6.0. The column was eluted with a linear gradient in 
ionic strength going from the equilibrating buffer to 
the same buffer containing 0.5 M NaCl. Due to the 
absence of clearly different electrophoretic properties 
of Hb Rainier versus the normal hemoglobin, purity 
had to be evaluated by amino acid analysis. 
The oxygen dissociation curves were determined by 
the method of Rossi et al. [6] . Stopped flow measure- 
ments were carried out with a Gibson-Durrum 
apparatus equipped with a 2 cm observation tube. 
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3. Results and discussion 
+1 I I 
The oxygen equilibrium curves of hemoglobin 
Rainier represented in fig. 1 show a value of n of 
exactly 1 at all pH values indicating complete loss of 
heme-heme interactions. 
The oxygen affinity is more than 10 times higher 
than that of normal human hemoglobin at neutral pH. 
The Bohr effect is still present although, in the 
alkaline range, is about r. -f lower than that of 
normal hemoglobin (fig. 2). 
The kinetic experiments show that: i) the rate for 
CO combination is much higher (about 10 times) 
than the overall rate for normal hemoglobin; ii) the rate 
of 0, dissociation, on the other hand, is lower (by a 
factor of about 5) (table 1). Both the combination 
with CO and the dissociation of 0, correspond to a 
simple bimolecular and monomolecular process, 
respectively, and show no sign of kinetic heterogeneity. 
-1 I I I 
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The results with hemoglobin Rainier are similar to Fig. 1. Hill plot of the oxygen equilibrium at 20” and different 
those obtained with other abnormal hemoglobins pH values (0 = pH 5.4;. = pH 6.5; q = pH 7.5; o = pH 8.2; A= 
insofar as they show loss of heme-heme interactions, pH 9.05; o = pH 9.7). Hemoglobin concentration ‘L 3 X l@ M 
in heme. 
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Fig. 2. Oxygen Bohr effect of hemoglobin Rainier (% 3 X low4 M in heme) at 20”, in 0.2 M phosphate and 0.05 M borate (over 
pH 9). Upper line indicates the Bohr effect of human hemoglobin A under the same conditions. 
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Table 1 
Kinetic constants for the reaction of ligands with hemoglobin 
Rainier (at 20”). 
koff 
-_____- 
PH 7 PH 9 
4.6 set-r 9.8 see-’ 
Ion 
PH 7 
1 X lo6 M-r set-r 
The results of the present work emphasize once 
again the important, role of the C-terminal region of 
the /3 chains and particularly of tyrosine HC2(145)/3 
in the ligand binding function of hemoglobin [4,7] . 
In fact the general functional properties of hemoglobin 
Rainier are similar to those of normal hemoglobin 
digested by carboxy peptidase A [8]. 
k,ff = dissociation rate constant with oxygen. 
I on = combination rate constant for carbon monoxide. 
high oxygen affinity and existence of a Bohr effect. 
Kinetically the changes in the ligand affinity are 
reflected both in a very large increase in the combination 
velocity and in a significant decrease in the dissociation 
velocity constant. 
Of particular significance is the kinetic homogeneity 
which, together with the value of n equal 1, shows that 
all the hemes, even associated with normal chains, have 
similarly altered reactivity. The situation is similar to 
that observed for other abnormal or chemically 
modified hemoglobins [l] . Perhaps the most striking 
and specific feature of hemoglobin Rainier is the 
presence of a substantial Bohr effect and in this con- 
nection it represents another case of dissociation 
between heme-heme interaction and Bohr effect. 
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